Published in Psychopharmacology (Berl) on December 01, 1997
Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci (2006) 1.39
Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov (2009) 1.30
Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J Neurochem (2004) 1.19
Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci (2010) 1.05
Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine. Neuropsychopharmacology (2014) 1.03
Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats. Drug Alcohol Depend (2011) 1.02
The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine. Neuroscience (2007) 0.96
First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians. Behav Pharmacol (2010) 0.94
Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience (2009) 0.92
Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. Neuron Glia Biol (2004) 0.92
Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice. Neurosci Lett (2013) 0.87
Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking. Addict Biol (2012) 0.84
Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self-administration and after extinction in rats. J Neurochem (2008) 0.84
A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia. Mol Brain (2014) 0.84
Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration. Psychopharmacology (Berl) (2010) 0.80
Complexity of VTA DA neural activities in response to PFC transection in nicotine treated rats. J Neuroeng Rehabil (2011) 0.79
Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice. Neuropsychopharmacology (2013) 0.79
Investigating the influence of PFC transection and nicotine on dynamics of AMPA and NMDA receptors of VTA dopaminergic neurons. J Neuroeng Rehabil (2011) 0.78
Cocaine-induced locomotor sensitization in rats correlates with nucleus accumbens activity on manganese-enhanced MRI. NMR Biomed (2015) 0.77
Facilitation of brain stimulation reward by MK-801 (dizocilpine) may be independent of D2-like dopamine receptor stimulation in rats. Psychopharmacology (Berl) (2005) 0.77
Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. Dialogues Clin Neurosci (2004) 0.77
Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology (Berl) (2017) 0.76
Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression. Eur Neuropsychopharmacol (2011) 0.76
Sensitizing exposure to amphetamine increases AMPA receptor phosphorylation without increasing cell surface expression in the rat nucleus accumbens. Neuropharmacology (2017) 0.75
Suppression of inhibitory G protein signaling in forebrain pyramidal neurons triggers plasticity of glutamatergic neurotransmission in the nucleus accumbens core. Neuropharmacology (2017) 0.75
The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health (1992) 3.02
How practical are recommendations for dietary control in phenylketonuria? Lancet (2002) 2.82
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell (1994) 2.46
Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci (2000) 1.94
D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse (1987) 1.69
Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci (1999) 1.65
Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther (1997) 1.61
Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur J Neurosci (2001) 1.57
Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther (1995) 1.54
Rates and relative risk of hospital admission among women in violent intimate partner relationships. Am J Public Health (2000) 1.52
Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci (1998) 1.50
Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J Neurosci (1988) 1.49
Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology (2001) 1.46
Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron (1997) 1.44
A case-control study of the effectiveness of bicycle safety helmets in preventing facial injury. Am J Public Health (1990) 1.41
Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology (1994) 1.31
Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets (2006) 1.30
Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc Natl Acad Sci U S A (1992) 1.24
Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther (1989) 1.22
Medical conditions and motor vehicle collision injuries in older adults. J Am Geriatr Soc (1994) 1.21
Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse (1999) 1.18
Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther (1991) 1.17
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci (1998) 1.17
Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J Neurosci (1986) 1.16
Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science (1983) 1.16
Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther (1984) 1.15
Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience (1995) 1.15
Motor vehicle collision injuries and sensory impairments of older drivers. Age Ageing (1994) 1.12
How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol (2012) 1.10
The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci (1995) 1.08
Microscopic examination of routine tonsillectomy specimens: is it necessary? Otolaryngol Head Neck Surg (1998) 1.08
Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration. Neuroscience (2010) 1.06
Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther (1993) 1.06
Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr (1998) 1.02
Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem (1996) 1.02
Risk factors for childhood sledding injuries: a case-control study. Pediatr Emerg Care (1992) 1.01
MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci (1994) 1.00
Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats. J Neurosci (2001) 0.99
The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis (2013) 0.99
Visual evoked potential-based acuity assessment in normal vision, artificially degraded vision, and in patients. Br J Ophthalmol (2008) 0.97
Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Res (1984) 0.97
Amphetamine and cocaine do not increase Narp expression in rat ventral tegmental area, nucleus accumbens or prefrontal cortex, but Narp may contribute to individual differences in responding to a novel environment. Eur J Neurosci (2002) 0.96
The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine. Neuroscience (2007) 0.96
Transient fungemia due to Candida lusitaniae. South Med J (1985) 0.96
Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse (1989) 0.94
Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neurosci Lett (1997) 0.93
A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci (1984) 0.93
Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse (1999) 0.92
Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci (1983) 0.91
Continuous magnetic resonance perfusion imaging acquisition during systemic thrombolysis in acute stroke. Cerebrovasc Dis (2013) 0.91
Glutamate receptor regulation of rat nucleus accumbens neurons in vivo. Synapse (1996) 0.91
Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment. Synapse (2000) 0.91
Defining subgroup size in fission-fusion societies. Folia Primatol (Basel) (1993) 0.89
Can the "state-dependency" hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists? Psychopharmacology (Berl) (1999) 0.89
D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse (1989) 0.89
Injury research: where should we go from here? Pediatrics (1989) 0.89
Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm Gen Sect (1991) 0.89
Popliteal vein thrombosis associated with femoral osteochondroma and popliteal artery pseudoaneurysm. Postgrad Med J (1995) 0.89
Maternal recognition of pregnancy signal or endocrine disruptor: the two faces of oestrogen during establishment of pregnancy in the pig. Soc Reprod Fertil Suppl (2006) 0.88
Tyramine-binding by synaptosomes from rat brain: effect of centrally active drugs. Biol Psychiatry (1977) 0.88
In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment. Neuroscience (2002) 0.88
Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr (2000) 0.87
Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. J Neurochem (2000) 0.87
Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J Pharmacol Exp Ther (1986) 0.87
A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett (1990) 0.87
Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex. J Neurochem (1999) 0.86
Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav Brain Res (1997) 0.86
Phenylethylamine in neuropsychiatric disorders. Gen Pharmacol (1983) 0.85
The forehead lift: endoscopic versus coronal approaches. Aesthetic Plast Surg (2001) 0.85
Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: modification by repeated amphetamine administration. J Neurochem (1998) 0.85
Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology (Berl) (1998) 0.84
Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. Mol Genet Metab (2013) 0.84
Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology (Berl) (2000) 0.83
Oral asymmetries during verbal and non-verbal movements of the mouth. Neuropsychologia (1987) 0.83
Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse (1997) 0.83
Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse (1999) 0.83
Effects of body condition score at parturition and postpartum protein supplementation on estrous behavior and size of the dominant follicle in beef cows. J Anim Sci (2008) 0.83
Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines. Life Sci (1982) 0.82
Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest (1989) 0.82
Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J Pharmacol Exp Ther (1988) 0.82
Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. Eur J Neurosci (1999) 0.82
Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology (Berl) (1992) 0.82
Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity. Eur J Pharmacol (1987) 0.82
Dietary management of urea cycle disorders: European practice. Mol Genet Metab (2013) 0.82
Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol (1995) 0.81
In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2. Int J Clin Pharmacol Ther Toxicol (1993) 0.81
In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge. Immunopharmacology (1993) 0.81
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Thromb Haemost (1997) 0.81
MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse (1994) 0.81
The expression of cocaine sensitization is not prevented by MK-801 or ibotenic acid lesions of the medial prefrontal cortex. Behav Brain Res (1999) 0.81